Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices
Published . Updated .
Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices Bloomberg.com
Directly affected
- PFE Pfizer
Named in this report.
Indirectly affected
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ASND ASCENDIS PHARMA A/S
GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ATYR ATYR PHARMA INC COM NEW
GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BBIO BRIDGEBIO PHARMA INC
GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- DVA DaVita HealthCare Partners, Inc.
GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- GEHC GE HEALTHCARE TECHNOLOGIES I
GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices Bloomberg.com
Source: Bloomberg.com
The price since 20 Sep 2026: Pfizer (PFE) versus the S&P 500
Since the first closing price after “Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices,” Pfizer (PFE) is +6.05%. The S&P 500 fund (SPY) is -0.89% over the same days, a +6.95% difference versus the market.
Disclosure records for Pfizer (PFE) within two months of 20 Sep 2026
- Gilbert Cisneros sell BridgeBio Pharma (BBIO) ($1,001 - $15,000). That is 9 days after publication, inside 30 days. The filing is listed beside the story “Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 9 days before publication, inside 30 days. The filing is listed beside the story “Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices.”
- Rohit Khanna sell Pfizer (PFE) ($1,001 - $15,000). That is 16 days before publication, inside 30 days. The filing is listed beside the story “Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 48 days before publication, inside 60 days. The filing is listed beside the story “Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices.”
- Donald J Trump buy Pfizer (PFE) ($100,001 - $250,000). That is 51 days before publication, inside 60 days. The filing is listed beside the story “Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 52 days before publication, inside 60 days. The filing is listed beside the story “Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 52 days before publication, inside 60 days. The filing is listed beside the story “Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices.”
- Donald J Trump sell Pfizer (PFE) ($15,001 - $50,000). That is 59 days before publication, inside 60 days. The filing is listed beside the story “Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices.”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Pfizer (PFE)
Companies tied to this story
- PFE Pfizer
For “Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices,” Pfizer (PFE) is linked, with no stored direction, high confidence. Reason on file: The reported development directly names PFIZER INC in the headline; GA resolved that company to PFE
- ACHC Acadia Healthcare
In “Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices,” Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
In “Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices,” Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence. Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
In “Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices,” aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence. Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BBIO BridgeBio Pharma
In “Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices,” BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence. Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DVA Davita
For “Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices,” Davita (DVA) is linked, with no stored direction, medium confidence. Reason on file: GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- GEHC GE HealthCare Technologies
For “Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices,” GE HealthCare Technologies (GEHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Pfizer (PFE)
The 20 Sep 2026 story “Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices” names Pfizer (PFE) because of this story.
For Pfizer (PFE), the reason on file says The reported development directly names PFIZER INC in the headline; GA resolved that company to PFE
Acadia Healthcare (ACHC) is here too. Its reason reads: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
The price range for Pfizer (PFE), and the dates in the story
ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. ASND traded between 219.69 and 240.84 across 20 sessions. The latest close on file is 229.99. PFE traded between 27.12 and 29.88 across 20 sessions. The latest close on file is 29.43.
What the saved facts support for Pfizer (PFE)
46 out of 100
“Pfizer to Share Revenue With HHS in Deal on Overseas Drug Prices” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.